Pre-pregnancy Health Behaviors and Gestational Weight Gain Among Hispanic/Latino Women: Hispanic Community Health Study/Study of Latinos.

Objective: To examine the association between preconception diet quality, sedentary behavior, and physical activity with gestational weight gain (GWG) among Hispanic/Latina women.

Methods: This was a retrospective cohort study of participants from visits 1 and 2 of the Hispanic Community Health Study/Study of Latinos and singleton pregnancies between the 2 visits. Diet quality (alternative healthy eating index/AHEI-2010), sedentary behaviors, and physical activity (global physical activity questionnaire) were measured at visit 1 and accounted for preconception health behaviors.

Nipple Discharge: Current Clinical and Imaging Evaluation.

Nipple discharge is a common complaint that is first evaluated with clinical assessment. Physiologic discharge does not require imaging other than routine screening mammography. Initial evaluation of pathologic nipple discharge involves mammography and ultrasound.

Lesion Localization Using Digital Breast Tomosynthesis: Where Did I Go Wrong?

The scroll bar on digital breast tomosynthesis has become an imperative tool that breast imaging radiologists rely on for help in identify lesions on the orthogonal view, targeting breast ultrasound, and performing challenging biopsies for one-view findings. The ability to predict the lesion location using the scroll bar not only saves time in the diagnostic setting but also reduces screening recalls when a finding can be confirmed as dermal. It is important, however, to recognize settings in which the location prediction can be misleading, such as for lesions in thin breast tissue or the anterior portion of the breast or if the breast is not appropriately positioned.

Artificial Intelligence in Breast Imaging: Potentials and Limitations.

Objective: The purpose of this article is to discuss potential applications of artificial intelligence (AI) in breast imaging and limitations that may slow or prevent its adoption.

Conclusion: The algorithms of AI for workflow improvement and outcome analyses are advancing. Using imaging data of high quality and quantity, AI can support breast imagers in diagnosis and patient management, but AI cannot yet be relied on or be responsible for physicians' decisions that may affect survival.

ACR Appropriateness Criteria Assessment of Fetal Well-Being.

Although there is limited evidence that antepartum testing decreases the risk for fetal death in low-risk pregnancies, women with high-risk factors for stillbirth should undergo antenatal fetal surveillance. The strongest evidence supporting antepartum testing pertains to pregnancies complicated by intrauterine fetal growth restriction secondary to uteroplacental insufficiency. The main ultrasound-based modalities to determine fetal health are the biophysical profile, modified biophysical profile, and duplex Doppler velocimetry.

Value-Based Reimbursement: Impact of Curtailing Physician Autonomy in Medical Decision Making.

Objective: In this article, we define value in the context of reimbursement and explore the effect of shifting reimbursement paradigms on the decision-making autonomy of a women's imaging radiologist.

Conclusion: The current metrics used for value-based reimbursement such as report turnaround time are surrogate measures that do not measure value directly. The true measure of a physician's value in medicine is accomplishment of better health outcomes, which, in breast imaging, are best achieved with a physician-patient relationship.

Training and standards for performance, interpretation, and structured reporting for supplemental breast cancer screening.

OBJECTIVE. To compensate for the reduction of mammography's sensitivity in women with dense breasts, supplemental screening can increase the cancer detection rate. The modalities suggested are MRI, which is the most sensitive and is indicated for women with the highest risk of breast cancer, and ultrasound, which is suggested for dense-breasted average-risk women.

Fibroblast growth factor receptor (FGFR)-4, but not FGFR-3 is expressed in the pregnant ovary.

The intraovarian mechanisms for follicle recruitment, growth, maturation, and ovulation are not well understood. The data suggest that fibroblast growth factor (FGF)-2 is expressed in granulosa and theca cells of growing and mature follicles and in luteal cells during pregnancy. Exogenous FGF-2 modulates steroidogenesis, stimulates tissue plasminogen activator (tPA), and induces germinal vesicle breakdown (GVBD) in cultured follicles.